Celiac artery stenting: a new strategy for patients with pancreaticoduodenal artery aneurysm associated with stenosis of the celiac artery

Yu-Wen Tien, Mamoru; Hsien-Li Kao, Mamoru; Hsiu-Po Wang
January 2004
Journal of Gastroenterology;2004, Vol. 39 Issue 1, p81
Academic Journal
We report a new strategy�celiac artery stenting�to relieve stenosis of the celiac arterial root. This was performed in two patients with pancreaticoduodenal artery (PDA) aneurysm associated with a stenotic celiac arterial root. The first patient was a 66-year-old man complaining of abrupt onset of upper abdominal pain. Abdominal computed tomography revealed a huge retroperitoneal hematoma behind the duodenum, and superior mesenteric artery (SMA) angiography demonstrated an aneurysm arising from inferior pancreaticoduodenal artery and celiac arteriography showed a stenotic celiac arterial root. Transcatheter embolization of the aneurysm was tried, but failed. Because of his unstable hemodynamics, emergent laparotomy with resection of the aneurysm was performed. Fourteen days after the operation, percutaneous transluminal angioplasty with celiac arterial stenting was done. The patient was discharged 2 days later, and has had no further bleeding episode for 3 years. The second patient was a 46-year-old woman, who also complained of acute upper abdominal pain. Abdominal computed tomography disclosed a huge retroperitoneal hematoma, and selective SMA angiography demonstrated an aneurysm arising from the inferior pancreaticoduodenal artery, and celiac arteriography showed a stenotic celiac arterial root. Because angiography showed no active bleeding from the aneurysm, percutaneous transluminal angioplastic stenting of the stenotic celiac artery was performed. She was discharged 5 days later and has had no further bleeding episode for 2 years. Celiac arterial stenting, as shown in our two patients, could be easily and safely employed in patients with PDA aneurysm associated with a stenotic celiac arterial root to release the stenosis of the celiac arterial root and to prevent further possible bleeding.


Related Articles

  • Molecular Mechanisms of Restenosis After Percutaneous Peripheral Angioplasty and Approach to Endovascular Therapy. Mongiardo, Annalisa; Curcio, Antonio; Spaccarotella, Carmen; Parise, Simona; Indolfi, Ciro // Current Drug Targets - Cardiovascular & Haematological Disorders;Sep2004, Vol. 4 Issue 3, p275 

    Atherosclerosis is the most common cause of peripheral arterial disease (PAD). Interventional procedures are the first treatments proposed for most PAD patients. Balloon angioplasty alone may offer good immediate results; however, has it been proposed that the addition of stents improves the...


    Discusses the origin and prevention of restenosis after percutaneous transluminal angioplasty (PTA) or insertion of vascular metallic endoprostheses, or stents. Effects of PTA and stent insertion; Development of intimal hyperplasia (IH) and its prevention.

  • Rupture of the Renal Artery After Cutting Balloon Angioplasty in a Young Woman With Fibromuscular Dysplasia. Oguzkurt, Levent; Tercan, Fahri; Gulcan, Oner; Turkoz, Riza // CardioVascular & Interventional Radiology;May2005, Vol. 28 Issue 3, p360 

    A 24-year-old woman with uncontrollable high blood pressure for 3 months had significant stenosis of the left renal artery caused by fibromuscular dysplasia (FMD). The lesion was resistant to percutaneous transluminal angioplasty at 18 atm with a semicompliant balloon. Angioplasy with a 6 ×...

  • Intracoronary photodynamic therapy reduces neointimal growth without suppressing endothelialisation in a porcine model. Waksman, R.; Leitch, I. M.; J. Roessler; Yazdi, H.; Seabron, R.; Tio, F.; Scott, R. W.; Grove, R. I.; Rychnovsky, S.; Robinson, B.; Pakala, R.; Cheneau, E. // Heart;Aug2006, Vol. 92 Issue 8, p1138 

    Objective: To examine the effects of intracoronary PhotoPoint photodynamic therapy (PDT) with a new photosensitiser, MV0611, in the overstretch balloon and stent porcine models of restenosis. Methods: 28 pigs were injected with 3 mg/kg of MV0611 systemically 4 h before the procedure. Animals...

  • CORONARY ARTERY DISEASE -- RESTENOSIS.  // Current Medical Literature: Interventional Cardiology Monitor;2004, Vol. 11 Issue 1, p26 

    Discusses the study "A randomized comparison of repeat stenting with balloon angioplasty in patients with in-stent restenosis," conducted by F. Alfonson, et al, and published in the "Journal of American College Cardiology" in 2003. Similarity of procedural success in both groups; Binary...

  • Arterial Stenosis, Aneurysm and Soft Tissue Tumor -- A Rare Combination: A Case Report. Schlosser, Volker; Adler, P.; Riese, K.H. // Vascular Surgery;Nov/Dec1985, Vol. 19 Issue 6, p450 

    Percutaneous transluminal angioplasty (PTA) is nowadays, 20 years after the first publication by Dotter, an accepted part of the therapeutic scheme of arterial occlusive disease treatment. Reocclusion and restenosis following PTA occur quite frequently, aneurysms, however, in the area of...

  • Advances in Vascular Brachytherapy Over the Last 100 Years: Focus on Femoropopliteal Applications. Schillinger, Martin; Minar, Erich // Journal of Endovascular Therapy;Dec2004 Supplement 2, Vol. 11, p180 

    Restenosis and the need for repeated interventions after percutaneous transluminal angioplasty (PTA) remain major drawbacks limiting a widespread application of this minimally invasive technique in the femoropopliteal segment. During the last decade, vascular brachytherapy (BT) emerged as a...

  • Celiac Artery Stenting to Facilitate Hepatic Yttrium-90 Radioembolization Therapy. Chamarthy, Murthy R.; Hughes, Terence W.; Gupta, Mohit; Vossen, Josephina A.; Velasco, Noel B.; Zinn, Kenneth M. // Case Reports in Radiology;2012, p1 

    Radioembolization offers a novel way to treat the nonresectable, liver predominant hepatic malignancies with better tumor response and overall progression-free survival rates. Transarterial catheter-based radioembolization procedure involves the hepatic arterial administration of glass- or...

  • Current Understanding of In-stent Restenosis and the Potential Benefit of Drug Eluting Stents. Froeschl, M.; Olsen, S.; Ma, X.; O'Brien, B. R. // Current Drug Targets - Cardiovascular & Haematological Disorders;Mar2004, Vol. 4 Issue 1, p103 

    Percutaneous transluminal coronary angioplasty has revolutionized the management of patients with coronary artery disease.Unfortunately,the procedure 's utility is limited by a frequent complication: restenosis.Coronary stenting prevents the elastic recoil and negative remodeling that can occur...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics